Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says
Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.
Extensions to the Global Fund’s existing HIV and TB grants to Nigeria will be funded from the 2017–2019 allocations
As mentioned elsewhere in this issue, the Board has approved 18-month costed extensions for two HIV and two TB grants to Nigeria.
TRP praises Uganda’s TB/HIV funding request to the Global Fund, but sends two matching funds requests back for iteration
In its review of Uganda’s TB/HIV funding request, the Technical Review Panel (TRP) praised the country for positioning the request as part of a more sustainable response, including a push to improve coordination with the private sector, and for scaling up interventions for key populations.
Bangladesh’s “ambitious, but realistic” TB funding request to the Global Fund receives positive reviews
The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.
The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.
Zimbabwe’s new Global Fund grants for TB/HIV are clearly aligned to the country’s epi profile and its national strategic plans, TRP says
In their recommendation to the Board on Zimbabwe’s TB/HIV funding request, the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) commented favorably on Zimbabwe’s inclusion of interventions to address barriers related to human rights and gender, and its focus on key populations for HIV, TB and STI care and treatment.
Catastrophe in Venezuela imperils the achievement of the Global Fund Strategy (2017-2022), says new report
Venezuela is in the middle of an unprecedented, state-made, complex humanitarian emergency. The public health crisis, which is just a symptom of the larger unraveling that is unfolding, has reached extreme levels. Essentials like soap and gloves have vanished from hospital floors. Life-saving medications are sometimes only available on the black market and cost half a month’s wages.
This year, I wrote three Global Fund funding requests for African HIV and TB programs. In Window 1 (20 March 2017), I wrote for Zimbabwe; in Window 2 (23 May 2017), I wrote for Zambia; and in Window 3 (28 August 2017), I wrote for Swaziland.
Both Zimbabwe’s and Zambia’s funding requests were invited to proceed directly to grant-making. Swaziland anticipates learning the outcome of its request in mid-October.
On 28 August 2017 (Window 3), Swaziland submitted a TB/HIV funding request to the Global Fund. The total request was for $93.8 million. When broken down, $47.2 million of this amount was within the country’s allocation, $1.5 million was a matching funds request for catalytic funding to prevent HIV among adolescent girls and young women (AGYW), and $45.1 million was a prioritized above allocation request (PAAR).
On 4 August 2017, Nigeria was notified that its TB/HIV funding request – submitted on 28 May 2017 – was not invited to proceed to grant-making. The Technical Review Panel (TRP) recommended a further iteration of the funding request. This means that the country must re-work and resubmit its funding request, addressing the TRP’s concerns. The country will resubmit its funding request in Window 4 on 7 February 2018.